W. Gleiber

发表

Liver Fibrosis and Metabolic Alterations in Adults with Alpha1 Antitrypsin Deficiency Caused by the Pi*ZZ Mutation.

C. Trautwein, F. Lammert, M. Miravitlles, 2019, Gastroenterology.

Identification of a chemoattractant for fibroblasts produced by human breast carcinoma cell lines.

E. Schiffmann, W. Gleiber, 1984, Cancer research.

Travelling with cystic fibrosis: recommendations for patients and care team members.

J. Bradley, J. Elborn, K. De Boeck, 2010, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer

F. Lordick, U. Martens, T. Decker, 2020, JAMA network open.

Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study.

J. Atz, C. Grohé, H. Müller-Huesmann, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Nintedanib plus docetaxel after progression on immune checkpoint inhibitor therapy: insights from VARGADO, a prospective study in patients with lung adenocarcinoma.

R. Kaiser, J. Atz, C. Grohé, 2019, Future oncology.

University of Southern Denmark Liver Fibrosis and Metabolic Alterations in Adults With alpha-1-antitrypsin Deficiency Caused by the Pi*ZZ Mutation Hamesch,

Ravi, C. Trautwein, Malin, 2019 .

Sino nasal inhalation of isotonic versus hypertonic saline (6.0%) in CF patients with chronic rhinosinusitis - Results of a multicenter, prospective, randomized, double-blind, controlled trial.

J. Mainz, J. Hentschel, J. Beck, 2016, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Cotranslational cleavage and glycosylation of the mineral oil-induced plasmacytoma-46B kappa chain precursor by plasmacytoma microsomes.

M. Green, W. Gleiber, 1980, Archives of biochemistry and biophysics.

Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).

W. Weichert, A. Stenzinger, Michael Thomas, 2020, Lung cancer.

Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis.

M. Friedrich-Rust, E. Herrmann, S. Zeuzem, 2013, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Colonization with multi-drug-resistant organisms negatively impacts survival in patients with non-small cell lung cancer

T. Wichelhaus, S. Stera, P. Kleine, 2020, PloS one.

Efficacy and safety of elexacaftor plus tezacaftor plus ivacaftor versus tezacaftor plus ivacaftor in people with cystic fibrosis homozygous for F508del-CFTR: a 24-week, multicentre, randomised, double-blind, active-controlled, phase 3b trial.

R. Fischer, S. Mulrennan, D. Waltz, 2021, The Lancet. Respiratory medicine.

Lung clearance index for monitoring early lung disease in alpha-1-antitrypsin deficiency.

M. Gappa, G. Hülskamp, R. Bals, 2016, Respiratory medicine.

Nintedanib + docetaxel in lung adenocarcinoma patients (pts) following treatment with immune checkpoint inhibitors (ICIs): Updated efficacy and safety results of the ongoing non-interventional study (NIS) VARGADO (NCT02392455).

R. Kaiser, J. Atz, C. Grohé, 2020 .

GLPG2737 in lumacaftor/ivacaftor-treated CF subjects homozygous for the F508del mutation: A randomized phase 2A trial (PELICAN).

A. Kempa, R. Fischer, K. Conrath, 2020, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)

C. Kortsik, T. Trarbach, W. Brueckl, 2023, JTO clinical and research reports.